NCT02078791

Brief Summary

The patients who were not pain control, are referred to the Chronic Pain Unit so its complexity is greater. Made two different interventions in three groups of people with fibromyalgia. In the first group will proceed to infiltrate the painful area with medication, in the second GPST (Group Problem Solving Technique) and the third group both techniques. GPST will want to identify problems that people associate with fibromyalgia, as well as proposed solutions and it they have been carried out successfully or not. Will be essential to identifying and solving problems and using techniques to increase assertiveness, self-esteem and eliminating negative thoughts. Observing if after performing any of these techniques (infiltration, GPST or both) there is a better quality of life, reduce thoughts of suicide, pain and improves sleep quality. We also analyzed the satisfaction or not with therapies received and perceived usefulness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jul 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

February 27, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 5, 2014

Completed
Last Updated

September 16, 2014

Status Verified

September 1, 2014

Enrollment Period

1.2 years

First QC Date

February 27, 2014

Last Update Submit

September 15, 2014

Conditions

Keywords

FibromyalgiaGroup Problem Solving Techniqueinfiltration

Outcome Measures

Primary Outcomes (1)

  • Change in pain perception Visual Analogical Scale (VAS)

    Baseline and 2 months

Secondary Outcomes (3)

  • Change in suicidal thoughts Plutchick Scale

    Baseline and 2 months

  • change in quality of sleep SCOPA questionnaire

    Baseline and 2 months

  • Change in health questionnaire EQ5D5L

    Baseline and 2 months

Other Outcomes (1)

  • Change in satisfaction and perceived usefulness questionnaire

    Baseline and 2 months

Study Arms (3)

Botox infiltration

EXPERIMENTAL

Botox infiltration in cervical region

Drug: Botox infiltration

Psychology therapy

EXPERIMENTAL

Problem solving group therapy

Behavioral: Psychology therapy

Botox infiltration & psychology therapy

EXPERIMENTAL

Botox infiltration in cervical region and problem solving group therapy.

Other: Botox infiltration & psychology therapy

Interventions

botox cervical infiltration in a group

Also known as: botox infiltration, and grup solving terapy group
Botox infiltration

Psychology problem solving therapy lead by specialized nurses.

Also known as: Problem solving group therapy
Psychology therapy

Botox infiltration in cervical region and psychology problem solving therapy lead by specialized nurses.

Also known as: Botox infiltration and problem solving group therapy.
Botox infiltration & psychology therapy

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosing Fibromyalgia.
  • Diagnosing Fibromyalgia + other causative pathology of chronic pain (chronic and / or chronic low back pain neck pain).
  • Acceptance of study participation by informed consent

You may not qualify if:

  • Severe disability that makes a first indication infiltration (disc herniation and / or lumbar spinal stenosis).
  • cognitive Impairment
  • Life expectancy less than 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Verge de la Cinta

Tortosa, Tarragona, 43500, Spain

Location

Related Links

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • PILAR MONTESÓ, phD

    University Rovira i Virgili

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

February 27, 2014

First Posted

March 5, 2014

Study Start

July 1, 2012

Primary Completion

September 1, 2013

Study Completion

February 1, 2014

Last Updated

September 16, 2014

Record last verified: 2014-09

Locations